122 related articles for article (PubMed ID: 590549)
1. Hemorrhage induced by intrauterine devices: control by local proteinase inhibition.
Tauber PF; Wolf AS; Herting W; Zaneveld LJ
Fertil Steril; 1977 Dec; 28(12):1375-7. PubMed ID: 590549
[TBL] [Abstract][Full Text] [Related]
2. A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia.
Milsom I; Andersson K; Andersch B; Rybo G
Am J Obstet Gynecol; 1991 Mar; 164(3):879-83. PubMed ID: 1900665
[TBL] [Abstract][Full Text] [Related]
3. [Management of abnormal bleeding in an intrauterine device user].
Desmons F; Adam-steen C
Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
[TBL] [Abstract][Full Text] [Related]
4. Oral micronised flavonoids versus tranexamic acid for treatment of heavy menstrual bleeding secondary to copper IUD use: a randomised double-blind clinical trial.
Alanwar A; Abbas AM; Hussain SH; Elhawwary G; Mansour DY; Faisal MM; Elshabrawy A; Eltaieb E
Eur J Contracept Reprod Health Care; 2018 Oct; 23(5):365-370. PubMed ID: 30247074
[TBL] [Abstract][Full Text] [Related]
5. Treatment of increased menstrual blood loss in IUD users.
Toppozada M
Contraception; 1987 Jul; 36(1):145-57. PubMed ID: 3311623
[TBL] [Abstract][Full Text] [Related]
6. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
7. Treatment of bleeding irregularities in women with copper-containing IUDs: a systematic review.
Godfrey EM; Folger SG; Jeng G; Jamieson DJ; Curtis KM
Contraception; 2013 May; 87(5):549-66. PubMed ID: 23199413
[TBL] [Abstract][Full Text] [Related]
8. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices.
Ylikorkala O; Viinikka L
Br J Obstet Gynaecol; 1983 Jan; 90(1):78-83. PubMed ID: 6336951
[TBL] [Abstract][Full Text] [Related]
9. Reduced menstrual blood loss by release of an antifibrinolytic agent from intrauterine contraceptive devices.
Tauber PF; Kloppel A; Goodpasture JC; Burns J; Ludwig H; Zaneveld LJ
Am J Obstet Gynecol; 1981 Jun; 140(3):322-8. PubMed ID: 7246636
[TBL] [Abstract][Full Text] [Related]
10. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
Wildemeersch D; Schacht E
Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
[TBL] [Abstract][Full Text] [Related]
11. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of an inhibitor-releasing matrix for intrauterine devices.
Burns JW; Goodpasture JC; Friel P; Wheeler R; Zaneveld LJ
Contraception; 1982 Nov; 26(5):521-33. PubMed ID: 6186431
[TBL] [Abstract][Full Text] [Related]
13. [Treatment by tranexamic acid in menorrhagia in women using intrauterine devices].
Bengtsson LP; Weström L
Lakartidningen; 1971 Aug; 68(33):3685-91. PubMed ID: 5129410
[TBL] [Abstract][Full Text] [Related]
14. Menorrhagia associated with the wearing of IUD--the results of treatment with clomiphene citrate.
Bahari CM; Gorodesky IG; Neri A; Schachter A
Eur J Obstet Gynecol Reprod Biol; 1982 Dec; 14(3):179-85. PubMed ID: 7160528
[TBL] [Abstract][Full Text] [Related]
15. Action of a prostaglandin synthetase inhibitor on IUD associated uterine bleeding.
Di Lieto A; Catalano D; Miranda L; Paladini A
Clin Exp Obstet Gynecol; 1987; 14(1):41-4. PubMed ID: 3102127
[TBL] [Abstract][Full Text] [Related]
16. The effect of a copper intra-uterine contraceptive device on the microbial ecology of the female genital tract.
Elhag KM; Bahar AM; Mubarak AA
J Med Microbiol; 1988 Apr; 25(4):245-51. PubMed ID: 3357191
[TBL] [Abstract][Full Text] [Related]
17. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid.
Dockeray CJ; Sheppard BL; Daly L; Bonnar J
Eur J Obstet Gynecol Reprod Biol; 1987 Apr; 24(4):309-18. PubMed ID: 2953634
[TBL] [Abstract][Full Text] [Related]
18. New developments in intrauterine devices.
Farr G
Netw Res Triangle Park N C; 1991 Sep; 12(2):9. PubMed ID: 12284281
[TBL] [Abstract][Full Text] [Related]
19. IUD-induced uterine bleeding.
El-badrawi HH; Hafez ES
Contracept Deliv Syst; 1980 Oct; 1(4):303-18. PubMed ID: 12262133
[TBL] [Abstract][Full Text] [Related]
20. [Prevention and treatment of IUD-induced menorrhagia with antifibrinolytic and antiprostaglandin drugs].
Zhonghua Fu Chan Ke Za Zhi; 1987 Sep; 22(5):291-4, 312. PubMed ID: 3443023
[No Abstract] [Full Text] [Related]
[Next] [New Search]